Huons Meditech Showcases at ‘WHX Dubai 2026’, Accelerating Expansion into the Middle Eastern Market

- Global Expansion of Aesthetic, Urology, and Infection Control Solutions -

Huons Meditech, a medical device subsidiary of Huons Group, is expanding its global reach by participating overseas exhibition.

Huons Meditech (CEO Changwoo Ha) announced on the 10th its participation in ‘World Health Expo Dubai 2026 (WHX Dubai 2026)’, held from February 9 to 12 in Dubai, UAE.

As the largest healthcare exhibition in the Middle East, ‘WHX Dubai’ brings together medical device companies, buyers, and healthcare professionals from across the Middle East, Africa, Europe, and Asia to share the latest technologies and industry trends.

Huons Meditech unveiled a wide range of flagship products across urology, aesthetics, and infection control at the exhibition. In the urology segment, the company introduced “URO-UEMXD”, the first domestically developed extracorporeal shock wave lithotripter that combines a shock wave head and ultrasound in an in-line structure. This innovation enables more intuitive and precise stone localization and treatment, enhancing clinical efficiency for medical professionals.

In aesthetics, Huons Meditech showcased its mesotherapy injector, “DermaShine Pro” alongside the newly launched “DermaShine Duo_RF”. DermaShine Pro, recognized globally for its precise drug delivery performance and user-friendly interface, once again drew strong interest at WHX Dubai. The company also emphasized the importance of using genuine needles through a global campaign, highlighting safety and quality assurance.

Debuting for the first time at an international exhibition, DermaShine Duo_RF integrates advanced drug delivery with low-energy radiofrequency (RF) technology, offering a hybrid solution that combines injectable treatments with skin tightening in a single device.

In infection control, Huons Meditech presented its endoscope washer-disinfector DR-02, providing hospitals and clinics with effective solutions for infection prevention and efficient device management.

Changwoo Ha (CEO of Huons Meditech) stated, “Participating in WHX Dubai 2026 allowed us to effectively showcase Huons Meditech’s technological strengths and product competitiveness to the global market. We will continue to drive innovation and enhance quality across aesthetics, urology, and infection control to strengthen our position as a global medical device company.”